SCHEMBL29357984

SCHEMBL29357984

CC(O)C(=O)OC1O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]1O

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 1/20 0.45
▸ MAPT P10636 1/20 0.44
▸ PRKD3 O94806 1/20 0.44
▸ PRKCG P05129 1/20 0.44
▸ PRKCB P05771 1/20 0.44
▸ PRKCA P17252 1/20 0.44
▸ PRKCH P24723 1/20 0.44
▸ PRKCI P41743 1/20 0.44
▸ PRKCE Q02156 1/20 0.44
▸ PRKCQ Q04759 1/20 0.44
▸ PRKCZ Q05513 1/20 0.44
▸ PRKCD Q05655 1/20 0.44
▸ PRKD1 Q15139 1/20 0.44
▸ ALDH1A1 P00352 1/20 0.44
▸ THRB P10828 1/20 0.44
▸ SLC28A3 Q9HAS3 2/20 0.43
▸ PYGB P11216 1/20 0.43
▸ LGALS8 O00214 1/20 0.41
▸ KDR P35968 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22439758 1.00 L3MBTL1 (0.45) L3MBTL1MAPTPRKD3PRKCGPRKCB
SCHEMBL30397543 1.00 L3MBTL1 (0.45) L3MBTL1MAPTPRKD3PRKCGPRKCB
SCHEMBL22439760 1.00 L3MBTL1 (0.45) L3MBTL1MAPTPRKD3PRKCGPRKCB
SCHEMBL3015191 1.00 L3MBTL1 (0.45) L3MBTL1MAPTPRKD3PRKCGPRKCB
SCHEMBL12290512 0.89 L3MBTL1 (0.46) L3MBTL1MAPTPRKD3PRKCGPRKCB
SCHEMBL8069003 0.89 L3MBTL1 (0.46) L3MBTL1MAPTPRKD3PRKCGPRKCB
SCHEMBL8136408 0.89 L3MBTL1 (0.46) L3MBTL1MAPTPRKD3PRKCGPRKCB
SCHEMBL27654959 0.89 L3MBTL1 (0.46) L3MBTL1MAPTPRKD3PRKCGPRKCB
SCHEMBL2337047 0.86 L3MBTL1 (0.44) L3MBTL1MAPTPRKD3PRKCGPRKCB
SCHEMBL27865347 0.86 L3MBTL1 (0.44) L3MBTL1MAPTPRKD3PRKCGPRKCB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115448964-A Hexose derivatives and their formulations and use 里斯本大学科学与技术学院 2022-12-09 — — CN disclosed
US-11229702-B1 High concentration formulations of adalimumab Coherus Biosciences, Inc. (US) 2022-01-25 — — US disclosed
Send feedback